{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:18:35Z","timestamp":1795061915655,"version":"4.10.2"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018557","name":"Science and\nTechnology Project of Nantong City","doi-asserted-by":"publisher","award":["KSZ2023141"],"award-info":[{"award-number":["KSZ2023141"]}],"id":[{"id":"10.13039\/501100018557","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-96666-4","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T02:48:04Z","timestamp":1744339684000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Study on the regulatory mechanism of luteolin inhibiting WDR72 on the proliferation and metastasis of non small cell lung cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Guanglin","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiashuai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"subi","family":"rahemu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiujian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"issue":"1","key":"96666_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S1470-2045(17)30694-0","volume":"19","author":"Herbst","year":"2018","unstructured":"HerbstRS et al. Cetuximab plus carboplatin and Paclitaxel with or\nwithout bevacizumab versus carboplatin and Paclitaxel with or without\nbevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study.\nLancet Oncol.\n19(1), 101\u2013114 (2018).","journal-title":"Lancet Oncol."},{"key":"96666_CR2","doi-asserted-by":"publisher","first-page":"13867","DOI":"10.1038\/ncomms13867","volume":"7","author":"CW Lin","year":"2016","unstructured":"Lin, C. W. et al. Daxx inhibits hypoxia-induced lung cancer cell\nmetastasis by suppressing the HIF-1\u03b1\/HDAC1\/Slug axis. Nat. Commun.\n7, 13867 (2016).","journal-title":"Nat. Commun."},{"issue":"1","key":"96666_CR3","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1038\/s41467-019-10877-8","volume":"10","author":"X Hu","year":"2019","unstructured":"Hu, X. et al. Multi-region exome sequencing reveals genomic\nevolution from preneoplasia to lung adenocarcinoma. Nat.\nCommun.\n10(1), 2978 (2019).","journal-title":"Nat. Commun."},{"key":"96666_CR4","doi-asserted-by":"crossref","unstructured":"Robichaux JP, Elamin YY, Vijayan R, et al. Pan-Cancer Landscape and\nAnalysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active\nInhibitor and Enhancer of T-DM1 Activity. Cancer Cell. 2019. 36(4):\n444\u2013457.e7.","DOI":"10.1016\/j.ccell.2019.09.001"},{"key":"96666_CR5","doi-asserted-by":"crossref","unstructured":"Lusk CM, Watza D, Dyson G, et al. Profiling the Mutational\nLandscape in Known Driver Genes and Novel Genes in African American Non-Small\nCell Lung Cancer Patients. Clin Cancer Res. 2019. 25(14):\n4300\u20134308.","DOI":"10.1158\/1078-0432.CCR-18-2439"},{"issue":"6","key":"96666_CR6","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3390\/ph16060858","volume":"16","author":"H Umar","year":"2023","unstructured":"Umar, H., Rizaner, N. & Usman, A. G. Prediction of cell\nmigration in MDA-MB 231 and MCF-7 human breast cancer cells treated with albizia\nLebbeck methanolic extract using multilinear regression and artificial\nIntelligence-Based models. Pharmaceuticals\n(Basel). 16(6), 858\n(2023).","journal-title":"Pharmaceuticals (Basel)"},{"key":"96666_CR7","doi-asserted-by":"crossref","unstructured":"Kargl J, Busch SE, Yang GH, et al. Neutrophils dominate the immune\ncell composition in non-small cell lung cancer. Nat Commun. 2017. 8:\n14381.","DOI":"10.1038\/ncomms14381"},{"issue":"3","key":"96666_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jtho.2016.11.2226","volume":"12","author":"Coroller","year":"2017","unstructured":"CorollerTP et al. Radiomic-Based pathological response prediction\nfrom primary tumors and lymph nodes in NSCLC. J. Thorac.\nOncol.\n12(3), 467\u2013476 (2017).","journal-title":"J. Thorac. Oncol."},{"key":"96666_CR9","doi-asserted-by":"crossref","unstructured":"Noro R, Ishigame T, Walsh N, et al. A Two-Gene Prognostic\nClassifier for Early-Stage Lung Squamous Cell Carcinoma in Multiple Large-Scale\nand Geographically Diverse Cohorts. J Thorac Oncol. 2017. 12(1):\n65\u201376.","DOI":"10.1016\/j.jtho.2016.08.141"},{"issue":"1","key":"96666_CR10","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1038\/s41598-022-06751-1","volume":"12","author":"K Katsura","year":"2022","unstructured":"Katsura, K. et al. WDR72 regulates vesicle trafficking in\nameloblasts. Sci. Rep.\n12(1), 2820 (2022).","journal-title":"Sci. Rep."},{"key":"96666_CR11","doi-asserted-by":"crossref","unstructured":"Feeney L, Mu\u00f1oz IM, Lachaud C, et al. RPA-Mediated\nRecruitment of the E3 Ligase RFWD3 Is Vital for Interstrand Crosslink Repair and\nHuman Health. Mol Cell. 2017. 66(5): 610\u2013621.e4.","DOI":"10.1016\/j.molcel.2017.04.021"},{"issue":"3","key":"96666_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.17796\/1053-4625-43.3.1","volume":"43","author":"A Garrocho-Rangel","year":"2019","unstructured":"Garrocho-Rangel, A., D\u00e1vila-Zapata, I.,\nMart\u00ednez-Rider, R., Ruiz-Rodr\u00edguez, S. &\nPozos-Guill\u00e9n, A. Dentinogenesis imperfecta type II in children: A\nscoping review. J. Clin. Pediatr. Dent.\n43(3), 147\u2013154 (2019).","journal-title":"J. Clin. Pediatr. Dent."},{"key":"96666_CR13","doi-asserted-by":"crossref","unstructured":"Katsura KA, Horst JA, Chandra D, et al. WDR72 models of structure\nand function: a stage-specific regulator of enamel mineralization. Matrix Biol.\n2014. 38: 48\u201358.","DOI":"10.1016\/j.matbio.2014.06.005"},{"key":"96666_CR14","doi-asserted-by":"crossref","unstructured":"Edo, G. I. & Ndudi,Raghda, W. S,et al.Nutritional\nimmunological effectsand mechanisms of chemical constituents from the homology\nof medicine and food. Phytochem Rev. (2024).\nNov 2.","DOI":"10.1007\/s11101-024-10034-0"},{"issue":"24","key":"96666_CR15","doi-asserted-by":"publisher","first-page":"25304","DOI":"10.18632\/aging.104131","volume":"12","author":"Y Zou","year":"2020","unstructured":"Zou, Y., Lu, Q., Yao, Q., Dong, D. & Chen, B. Identification\nof novel prognostic biomarkers in renal cell carcinoma. Aging (Albany NY). 12(24),\n25304\u201325318 (2020).","journal-title":"Aging (Albany NY)"},{"key":"96666_CR16","doi-asserted-by":"crossref","unstructured":"Kim YC, Kim S, Kim HK, et al. Genome-Wide Association Study\nIdentifies Eight Novel Loci for Susceptibility of Scrub Typhus and Highlights\nImmune-Related Signaling Pathways in Its Pathogenesis. Cells. 2021. 10(3):\n570.","DOI":"10.3390\/cells10030570"},{"issue":"3","key":"96666_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4149\/neo_2013_0391","volume":"60","author":"J Mares","year":"2013","unstructured":"Mares, J. et al. Prediction of recurrence in low and intermediate\nrisk non-muscle invasive bladder cancer by real-time quantitative PCR analysis:\ncDNA microarray results. Neoplasma\n60(3), 295\u2013301 (2013).","journal-title":"Neoplasma"},{"key":"96666_CR18","doi-asserted-by":"crossref","unstructured":"Ouyang X, Shi X, Huang N, et al. WDR72 Enhances the Stemness of\nLung Cancer Cells by Activating the AKT\/HIF-1\u03b1 Signaling Pathway. J\nOncol. 2022. 2022: 5059588.","DOI":"10.1155\/2022\/5059588"},{"key":"96666_CR19","doi-asserted-by":"crossref","unstructured":"Howles SA, Wiberg A, Goldsworthy M, et al. Genetic variants of\ncalcium and vitamin D metabolism in kidney stone disease. Nat Commun. 2019.\n10(1): 5175.","DOI":"10.1038\/s41467-019-13145-x"},{"issue":"2","key":"96666_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bbrc.2017.02.079","volume":"485","author":"JN Li","year":"2017","unstructured":"Li, J. N. et al. Synergy of Raddeanin A and cisplatin induced\ntherapeutic effect enhancement in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun.\n485(2), 335\u2013341\n(2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"96666_CR21","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1021\/acs.chemrev.7b00588","volume":"118","author":"Z Sun","year":"2018","unstructured":"Sun, Z., Fridrich, B., de Santi, A., Elangovan, S. & Barta,\nK. Bright side of lignin depolymerization: toward new platform chemicals.\nChem. Rev.\n118(2), 614\u2013678\n(2018).","journal-title":"Chem. Rev."},{"key":"96666_CR22","doi-asserted-by":"crossref","unstructured":"Wang K, Chen Q, Shao Y, et al. Anticancer activities of TCM and\ntheir active components against tumor metastasis. Biomed Pharmacother. 2021.\n133: 111044.","DOI":"10.1016\/j.biopha.2020.111044"},{"key":"96666_CR23","doi-asserted-by":"crossref","unstructured":"de Boer RA, Meijers WC, van der Meer P, van Veldhuisen DJ. Cancer\nand heart disease: associations and relations. Eur J Heart Fail. 2019. 21(12):\n1515\u20131525.","DOI":"10.1002\/ejhf.1539"},{"key":"96666_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s40495-024-00381-z","volume":"11","author":"RJ Moses","year":"2025","unstructured":"Moses, R. J. et al. The role of selenium in cancer. Curr. Pharmacol. Rep.\n11, 4 (2025).","journal-title":"Curr. Pharmacol. Rep."},{"key":"96666_CR25","doi-asserted-by":"crossref","unstructured":"Huang H, Fang J, Fan X, et al. Advances in Molecular Mechanisms for\nTraditional Chinese Medicine Actions in Regulating Tumor Immune Responses. Front\nPharmacol. 2020. 11: 1009.","DOI":"10.3389\/fphar.2020.01009"},{"issue":"2","key":"96666_CR26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1161\/CIRCRESAHA.117.309008","volume":"122","author":"D Mozaffarian","year":"2018","unstructured":"Mozaffarian, D. & Wu, J. Flavonoids, dairy foods, and\ncardiovascular and metabolic health: A review of emerging biologic pathways.\nCirc. Res.\n122(2), 369\u2013384\n(2018).","journal-title":"Circ. Res."},{"key":"96666_CR27","doi-asserted-by":"crossref","unstructured":"Jiang ZB, Wang WJ, Xu C, et al. Luteolin and its derivative\napigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity\nin KRAS-mutant lung cancer. Cancer Lett. 2021. 515:\n36\u201348.","DOI":"10.1016\/j.canlet.2021.05.019"},{"key":"96666_CR28","doi-asserted-by":"crossref","unstructured":"Huang L, Kim MY, Cho JY. Immunopharmacological Activities of\nLuteolin in Chronic Diseases. Int J Mol Sci. 2023. 24(3):\n2136.","DOI":"10.3390\/ijms24032136"},{"key":"96666_CR29","doi-asserted-by":"publisher","first-page":"108539","DOI":"10.1016\/j.abb.2020.108539","volume":"692","author":"B Wu","year":"2020","unstructured":"Wu, B. et al. Luteolin enhances TRAIL sensitivity in non-small cell\nlung cancer cells through increasing DR5 expression and Drp1-mediated\nmitochondrial fission. Arch. Biochem.\nBiophys.\n692, 108539 (2020).","journal-title":"Arch. Biochem. Biophys."},{"issue":"2","key":"96666_CR30","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/ijms19020447","volume":"19","author":"ZQ Jiang","year":"2018","unstructured":"Jiang, Z. Q. et al. Luteolin inhibits tumorigenesis and induces\napoptosis of Non-Small cell lung cancer cells via regulation of MicroRNA-34a-5p.\nInt. J. Mol. Sci.\n19(2), 447 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"96666_CR31","doi-asserted-by":"crossref","unstructured":"Zuo W, Liu N, Zeng Y, et al. Luteolin Ameliorates Experimental\nPulmonary Arterial Hypertension via Suppressing Hippo-YAP\/PI3K\/AKT Signaling\nPathway. Front Pharmacol. 2021. 12: 663551.","DOI":"10.3389\/fphar.2021.663551"},{"key":"96666_CR32","doi-asserted-by":"crossref","unstructured":"Mu J, Ma H, Chen H, Zhang X, Ye M. Luteolin Prevents UVB-Induced\nSkin Photoaging Damage by Modulating SIRT3\/ROS\/MAPK Signaling: An in vitro and\nin vivo Studies. Front Pharmacol. 2021. 12: 728261.","DOI":"10.3389\/fphar.2021.728261"},{"key":"96666_CR33","doi-asserted-by":"crossref","unstructured":"Li L, Luo W, Qian Y, et al. Luteolin protects against diabetic\ncardiomyopathy by inhibiting NF-\u03baB-mediated inflammation and activating\nthe Nrf2-mediated antioxidant responses. Phytomedicine. 2019. 59:\n152774.","DOI":"10.1016\/j.phymed.2018.11.034"},{"key":"96666_CR34","doi-asserted-by":"publisher","first-page":"102858","DOI":"10.1016\/j.critrevonc.2019.102858","volume":"146","author":"F Passiglia","year":"2020","unstructured":"Passiglia, F. et al. Treatment of advanced non-small-cell lung\ncancer: the 2019 AIOM (Italian association of medical Oncology) clinical\npractice guidelines. Crit. Rev. Oncol.\nHematol.\n146, 102858 (2020).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"96666_CR35","doi-asserted-by":"crossref","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A.\nGlobal cancer statistics, 2012. CA Cancer J Clin. 2015. 65(2):\n87\u2013108.","DOI":"10.3322\/caac.21262"},{"key":"96666_CR36","doi-asserted-by":"crossref","unstructured":"Prasher P, Sharma M, Singh SK, et al. Luteolin: a flavonoid with a\nmultifaceted anticancer potential. Cancer Cell Int. 2022. 22(1):\n386.","DOI":"10.1186\/s12935-022-02808-3"},{"issue":"10","key":"96666_CR37","first-page":"729","volume":"17","author":"LQ Wan","year":"2019","unstructured":"Wan, L. Q., Tan, Y., Jiang, M. & Hua, Q. The prognostic\nimpact of traditional Chinese medicine monomers on tumor-associated macrophages\nin non-small cell lung cancer. Chin. J. Nat.\nMed.\n17(10), 729\u2013737\n(2019).","journal-title":"Chin. J. Nat. Med."},{"key":"96666_CR38","doi-asserted-by":"crossref","unstructured":"Li Z, Feiyue Z, Gaofeng L. Traditional Chinese medicine and lung\ncancer\u2013From theory to practice. Biomed Pharmacother. 2021. 137:\n111381.","DOI":"10.1016\/j.biopha.2021.111381"},{"key":"96666_CR39","doi-asserted-by":"crossref","unstructured":"Wei Z, Chen J, Zuo F, et al. Traditional Chinese Medicine has great\npotential as candidate drugs for lung cancer: A review. J Ethnopharmacol. 2023.\n300: 115748.","DOI":"10.1016\/j.jep.2022.115748"},{"key":"96666_CR40","doi-asserted-by":"crossref","unstructured":"Su XL, Wang JW, Che H, et al. Clinical application and mechanism of\ntraditional Chinese medicine in treatment of lung cancer. Chin Med J (Engl).\n2020. 133(24): 2987\u20132997.","DOI":"10.1097\/CM9.0000000000001141"},{"key":"96666_CR41","doi-asserted-by":"crossref","unstructured":"Wei X, Leng X, Li G, Wang R, Chi L, Sun D. Advances in research on\nthe effectiveness and mechanism of Traditional Chinese Medicine formulas for\ncolitis-associated colorectal cancer. Front Pharmacol. 2023. 14:\n1120672.","DOI":"10.3389\/fphar.2023.1120672"},{"key":"96666_CR42","doi-asserted-by":"crossref","unstructured":"Wang S, Yang S, Yang X, Deng D, Li J, Dong M. Research Progress of\nTraditional Chinese Medicine Monomers in Reversing Multidrug Resistance of\nBreast Cancer. Am J Chin Med. 2023. 51(3): 575\u2013594.","DOI":"10.1142\/S0192415X23500283"},{"key":"96666_CR43","doi-asserted-by":"crossref","unstructured":"Singh Tuli H, Rath P, Chauhan A, et al. Luteolin, a Potent\nAnticancer Compound: From Chemistry to Cellular Interactions and Synergetic\nPerspectives. Cancers (Basel). 2022. 14(21): 5373.","DOI":"10.3390\/cancers14215373"},{"key":"96666_CR44","doi-asserted-by":"crossref","unstructured":"Diniz L, Elshabrawy HA, Souza M, Duarte A, Madhav N, de Sousa DP.\nRenoprotective Effects of Luteolin: Therapeutic Potential for\nCOVID-19-Associated Acute Kidney Injuries. Biomolecules. 2022. 12(11):\n1544.","DOI":"10.3390\/biom12111544"},{"key":"96666_CR45","doi-asserted-by":"crossref","unstructured":"Seelinger G, Merfort I, W\u00f6lfle U, Schempp CM.\nAnti-carcinogenic effects of the flavonoid luteolin. Molecules. 2008. 13(10):\n2628\u20132651.","DOI":"10.3390\/molecules13102628"},{"key":"96666_CR46","doi-asserted-by":"crossref","unstructured":"Zhou YS, Cui Y, Zheng JX, et al. Luteolin relieves lung\ncancer-induced bone pain by inhibiting NLRP3 inflammasomes and glial activation\nin the spinal dorsal horn in mice. Phytomedicine. 2022. 96:\n153910.","DOI":"10.1016\/j.phymed.2021.153910"},{"key":"96666_CR47","doi-asserted-by":"crossref","unstructured":"Fang B, Chen X, Wu M, et al. Luteolin inhibits angiogenesis of the\nM2\u2013like TAMs via the downregulation of hypoxia inducible\nfactor\u20131\u03b1 and the STAT3 signalling pathway under hypoxia. Mol Med\nRep. 2018. 18(3): 2914\u20132922.","DOI":"10.3892\/mmr.2018.9250"},{"key":"96666_CR48","doi-asserted-by":"crossref","unstructured":"Saleem HM, Ramaiah P, Gupta J, et al. Nanotechnology-empowered lung\ncancer therapy: From EMT role in cancer metastasis to application of\nnanoengineered structures for modulating growth and metastasis. Environ Res.\n2023. 232: 115942.","DOI":"10.1016\/j.envres.2023.115942"},{"key":"96666_CR49","doi-asserted-by":"crossref","unstructured":"Ren Y, Mao X, Xu H, et al. Ferroptosis and EMT: key targets for\ncombating cancer progression and therapy resistance. Cell Mol Life Sci. 2023.\n80(9): 263.","DOI":"10.1007\/s00018-023-04907-4"},{"key":"96666_CR50","doi-asserted-by":"crossref","unstructured":"Hussain Y, Cui JH, Khan H, Aschner M, Batiha GE, Jeandet P.\nLuteolin and cancer metastasis suppression: focus on the role of epithelial to\nmesenchymal transition. Med Oncol. 2021. 38(6): 66.","DOI":"10.1007\/s12032-021-01508-8"},{"key":"96666_CR51","doi-asserted-by":"crossref","unstructured":"Akrida I, Papadaki H. Adipokines and epithelial-mesenchymal\ntransition (EMT) in cancer. Mol Cell Biochem. 2023. 478(11):\n2419\u20132433.","DOI":"10.1007\/s11010-023-04670-x"},{"key":"96666_CR52","doi-asserted-by":"crossref","unstructured":"Lee SK, Seymen F, Lee KE, et al. Novel WDR72 mutation and\ncytoplasmic localization. J Dent Res. 2010. 89(12): 1378-82.","DOI":"10.1177\/0022034510382117"},{"key":"96666_CR53","doi-asserted-by":"crossref","unstructured":"Wu Y, Zhang X, Wei X, et al. Development of an Individualized\nUbiquitin Prognostic Signature for Clear Cell Renal Cell Carcinoma. Front Cell\nDev Biol. 2021. 9: 684643.","DOI":"10.3389\/fcell.2021.684643"},{"key":"96666_CR54","doi-asserted-by":"crossref","unstructured":"Warnecke-Eberz U, Metzger R, H\u00f6lscher AH, Drebber U,\nBollschweiler E. Diagnostic marker signature for esophageal cancer from\ntranscriptome analysis. Tumour Biol. 2016. 37(5): 6349-58.","DOI":"10.1007\/s13277-015-4400-4"},{"key":"96666_CR55","doi-asserted-by":"crossref","unstructured":"Zhang Z, Wang Q, Zhang M, et al. Comprehensive analysis of the\ntranscriptome-wide m6A methylome in colorectal cancer by MeRIP sequencing.\nEpigenetics. 2021. 16(4): 425\u2013435.","DOI":"10.1080\/15592294.2020.1805684"},{"key":"96666_CR56","doi-asserted-by":"crossref","unstructured":"Wang Q, Li C, Tang P, Ji R, Chen S, Wen J. A Minimal lncRNA-mRNA\nSignature Predicts Sensitivity to Neoadjuvant Chemotherapy in Triple-Negative\nBreast Cancer. Cell Physiol Biochem. 2018. 48(6):\n2539\u20132548.","DOI":"10.1159\/000492698"},{"key":"96666_CR57","unstructured":"Schulten HJ, Hussein D, Al-Adwani F, et al. Microarray expression\nprofiling identifies genes, including cytokines, and biofunctions, as\ndiapedesis, associated with a brain metastasis from a papillary thyroid\ncarcinoma. Am J Cancer Res. 2016. 6(10): 2140\u20132161."},{"key":"96666_CR58","doi-asserted-by":"crossref","unstructured":"Rezaei S, Nikpanjeh N, Rezaee A, et al. PI3K\/Akt signaling in\nurological cancers: Tumorigenesis function, therapeutic potential, and therapy\nresponse regulation. Eur J Pharmacol. 2023. 955: 175909.","DOI":"10.1016\/j.ejphar.2023.175909"},{"key":"96666_CR59","doi-asserted-by":"crossref","unstructured":"Liu T, Wang W, Li X, et al. Advances of phytotherapy in ischemic\nstroke targeting PI3K\/Akt signaling. Phytother Res. 2023. 37(12):\n5509\u20135528.","DOI":"10.1002\/ptr.7994"},{"key":"96666_CR60","doi-asserted-by":"crossref","unstructured":"Verma K, Jaiswal R, Paliwal S, Dwivedi J, Sharma S. An insight into\nPI3k\/Akt pathway and associated protein-protein interactions in metabolic\nsyndrome: A recent update. J Cell Biochem. 2023. 124(7):\n923\u2013942.","DOI":"10.1002\/jcb.30433"},{"key":"96666_CR61","doi-asserted-by":"crossref","unstructured":"Maharati A, Moghbeli M. PI3K\/AKT signaling pathway as a critical\nregulator of epithelial-mesenchymal transition in colorectal tumor cells. Cell\nCommun Signal. 2023. 21(1): 201.","DOI":"10.1186\/s12964-023-01225-x"},{"key":"96666_CR62","doi-asserted-by":"crossref","unstructured":"He Y, Sun MM, Zhang GG, et al. Targeting PI3K\/Akt signal\ntransduction for cancer therapy. Signal Transduct Target Ther. 2021. 6(1):\n425.","DOI":"10.1038\/s41392-021-00828-5"},{"key":"96666_CR63","doi-asserted-by":"crossref","unstructured":"Tania M, Khan MA, Fu J. Epithelial to mesenchymal transition\ninducing transcription factors and metastatic cancer. Tumour Biol. 2014. 35(8):\n7335-42.","DOI":"10.1007\/s13277-014-2163-y"},{"key":"96666_CR64","doi-asserted-by":"crossref","unstructured":"Karimi Roshan M, Soltani A, Soleimani A, Rezaie Kahkhaie K, Afshari\nAR, Soukhtanloo M. Role of AKT and mTOR signaling pathways in the induction of\nepithelial-mesenchymal transition (EMT) process. Biochimie. 2019. 165:\n229\u2013234.","DOI":"10.1016\/j.biochi.2019.08.003"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96666-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96666-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96666-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:05:55Z","timestamp":1795061155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96666-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["96666"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-96666-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"19 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Clarification","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Editor's Note: Readers are alerted that the reliability of data presented in this manuscript is currently in question. Further editorial action will be taken, if appropriate, once the investigation into the concerns is complete.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Animal Ethics Committee of Jiangsu\nMedical Vocational College (NO. SYLL- 2023 -\u2009917) and followed the\nDeclaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"12398"}}